Release Date: 29/07/11 18:43 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 5.11MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%